Related Experiment Videos
Glucocorticoid-induced osteoporosis
1University of Kansas Medical Center, Kansas City.
Rheumatic Diseases Clinics of North America
|August 1, 1994
Abstract:
Glucocorticoids are important in the management of rheumatic diseases. Bone loss is one of the most devastating side effects of glucocorticoids because they inhibit calcium transport, cause secondary hyperparathyroidism, hypogonadism, and impairment of osteoblast function. Efforts to control these side effects minimize bone loss.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Causes of secondary osteoporosis.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry·2013
Importance of bone mineral density measurements in evaluating fragility bone fracture risk in Asian Indian men.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2010
Spinal extension exercises prevent natural progression of kyphosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2008
Estradiol rapidly inhibits osteoclastogenesis and RANKL expression in bone marrow cultures in postmenopausal women: a pilot study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2007
Femoral bone mineral density in patients with heart failure.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2006
Artificial Intelligence Regulation in the United States: Current Landscape and Implications for Rheumatology.
Rheumatic diseases clinics of North America·2026
The Role of Artificial Intelligence in Medical Education and Training: Implications for Rheumatology.
Rheumatic diseases clinics of North America·2026
Sources of Bias in Clinical Artificial Intelligence and Applications in Rheumatology.
Rheumatic diseases clinics of North America·2026
Toward Bridging the Gap from Artificial Intelligence in Clinical Research to Clinical Practice in Rheumatology: The Mayo Experience.
Rheumatic diseases clinics of North America·2026
Machine Learning-Enhanced Autoantibody Discovery and Diagnostics in Systemic Autoimmune Rheumatic Diseases.
Rheumatic diseases clinics of North America·2026
Artificial Intelligence in Musculoskeletal Imaging: Innovations and Clinical Impact in Rheumatology.
Rheumatic diseases clinics of North America·2026
Trends in diagnosis of amyloid kidney disease in people who inject drugs (PWID).
Preventive medicine reports·2026
Thiazole-Substituted Benzoylpiperazines with Anti-Cancer and Anti-Inflammatory Activities: Comparative Evaluation with Lercanidipine.
International journal of molecular sciences·2026